Abstracts tagged "MRI"

Abstract Number: 852 • 2013 ACR/ARHP Annual Meeting
Systemic Lupus Erythematosous and Primary Sjogren’s Syndrome May Display Joint Erosions On MRI As Well As Healthy Control, But Cannot Be Considered As Erosive Disease Such As Rheumatoid Arthritis: : An MRI Observational Study Of 90 Subjects
Frédérique Gandjbakhch¹, Violaine Foltz², Jérôme Renoux³, Nahalie Cozic⁴, Nathalie Costedoat-Chalumeau⁵, Damien Sene⁶, Guillaume Mercy⁷, Zahir Amoura⁸, Jean-Charles Piette⁹, Nathalie Morel¹⁰, Pierre Bourgeois¹¹ and Bruno Fautrel¹², ¹Department of Rheumatology, APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, ²APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, ³Radiology, Pitie-Salpetriere Hospital, Paris, France, ⁴APHP, Pitie Salpetriere Hospital, department of statistics, Paris, France, ⁵Internal Medicine, Hopital Cochin, Paris, France, ⁶Internal Medicine, Hopital Lariboisière, Paris, France, ⁷APHP, Pitie-Salpétrière Hospital, paris, France, ⁸Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, ⁹Department of Internal Medicine 1., CHU Pitié-Salpêtrière, Paris, France, ¹⁰Internal Medicine, Groupe Hospitalier Pitié-Salpétrière, Paris, France, ¹¹Rheumatology, APHP,Pitie-Salpetriere Hospital, Paris 6, Paris, France, ¹²Paris 6 – Pierre et Marie Curie University; AP-HP, Rheumatology, Pitié-Salpêtrière Hospital, - GRC-UPMC 08 – EEMOIS, Paris, France
Background/Purpose: Recent studies tend to demonstrate presence of MRI erosion in Systemic Lupus Erythematosous (SLE) and primary Sjogren’s syndrome (pSS). The objective of this study…
Abstract Number: 1954 • 2013 ACR/ARHP Annual Meeting
advantages Of a Combined Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) For Hand and Feet: Does The Ramris Of The Hand Alone Underestimate Disease Activity and Progression?
Dr. Philipp Sewerin¹, Dr. Christian Buchbender², Dr. Stefan Vordenbäumen¹, Dr. Axel Scherer², Dr. Falk Miese², Dr. Ralph Brinks³, Dr. Hans-Jörg Wittsack⁴, Prof. Dr. Gerald Antoch⁴, Prof. Dr. Matthias Schneider³ and Prof. Dr. Benedikt Ostendorf¹, ¹Department of Rheumatology, Univ. Duesseldorf, Düsseldorf, Germany, ²Department of Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany, ³Department of Rheumatology, Univ. Duesseldorf, Duesseldorf, Germany, ⁴Department Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany
Background/Purpose: To evaluate a combined rheumatoid arthritis magnetic resonance imaging score (RAMRIS) for hand and foot (HaF-score) in rheumatoid arthritis (RA). Methods: Magnetic resonance imaging…
Abstract Number: 819 • 2013 ACR/ARHP Annual Meeting
Low Diagnostic Utility Of Candidate Definitions For a Positive MRI Of The Spine In Axial Spondyloarthritis
Ulrich Weber¹, Veronika Zubler², Zheng Zhao³, Robert GW Lambert⁴, Kaspar Rufibach⁵, Stanley Chan⁶, Susanne Juhl Pedersen⁷, Mikkel Ostergaard⁸ and Walter P. Maksymowych⁹, ¹Rheumatology, Balgrist University Hospital, Zurich, Switzerland, ²Radiology, Balgrist University Hospital, Zurich, Switzerland, ³Department of Rheumatology, University of Alberta and PLA General Hospital, Beijing, PR China, Beijing, AB, China, ⁴Radiology, University of Alberta, Edmonton, AB, Canada, ⁵rePROstat, Basel, Switzerland, ⁶Division of Ophthalmology, University of Alberta, Edmonton, AB, Canada, ⁷Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, ⁸Copenhagen Center for Arthritis Research, Glostrup, Denmark, ⁹Medicine, University of Alberta, Edmonton, AB, Canada
Background/Purpose: A recent consensus statement based on a systematic literature review by the Assessment of SpondyloArthritis International Society suggested the presence of ≥3 corner inflammatory…
Abstract Number: 1041 • 2012 ACR/ARHP Annual Meeting
Whole-Body Magnetic Resonance Imaging – A New Diagnostic Tool in the Assessment of Activity in Juvenile Dermatomyositis Patients?
Tania Monteiro de Castro¹, Henrique Lederman¹, Maria Teresa Terreri², Wanda I. Caldana¹, Edmar Zanoteli³ and Maria Odete Hilario¹, ¹Federal University of São Paulo, São Paulo, Brazil, ²Universidade Federal de São Paulo/UNIFESP, São Paulo, Brazil, ³University of São Paulo, São Paulo, Brazil
Background/Purpose: Juvenile dermatomyositis (JDM) is a rare autoimmune disorder, but remains the most commonly chronic inflammatory myopathy among children. A redefinition of the diagnostic criteria…

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].